Process Research & Development
Highly trained and experienced ARCINOVA chemists can support all aspects of drug substance development. Typically, we work with clients to select and develop optimum synthetic routes for drug substance manufacture, with a view to process economy, product purity, process scalability and safety. The drug substance can be scaled to multi-kg production volumes to support direct client supply, or as part of an integrated drug substance / drug product package where the supply of both in house developed drug substance and drug product can be carefully managed.
MHRA SymposiumThe 2018 MHRA Symposium will be attended by John McRoberts, Head of QA.
MHRA SymposiumDates: 20th NovemberLocation: London, UK
AAPS: PharmSci360This years' PharmSci360 conference will be attended by Masha Kononov, Senior Director Emerging Biotech US.
AAPS: PharmSci360Dates: 4th - 7th NovemberLocation: Washington DC, US
Bio-Europe 2018Bio-Europe autumn conference will be attended by Nathalie Huther, Business Development Manager Europe.
Bio-Europe 2018Dates: 5th - 7th NovemberLocation: Copenhagen, Denmark